A low haemoglobin count, older age and high BMI are possible risk factors for developing nerve damage after cancer treatment, a UNSW-led study has found.
UNSW Sydney and the Garvan Institute of Medical Research researchers will lead the program, thanks to a $3.75 million grant from the Cancer Institute NSW.
UNSW researchers working on some of the most aggressive cancers including neuroblastoma, leukaemia, and pancreatic and breast tumours have received major backing from The Cancer Institute NSW.
UNSW researchers working to fast-track cancer treatments from the laboratory to the bedside have received major backing in the latest round of funding from The Cancer Institute NSW.
UNSW research into childhood cancer and treatments for patients with nerve damage has received major backing in the latest round of funding from The Cancer Institute NSW.
